Skip to content
HowShorted

CAPRICOR THERAPEUTICS, INC. short interest in 2022

In 2022, CAPRICOR THERAPEUTICS, INC.'s disclosed short interest ran from 2.28% of shares outstanding on 14 Jan 2022 to 1.35% on 30 Dec 2022, a change of -0.93 percentage points. The year's high was 3.87% on 31 Jan 2022 and its low 0.88% on 15 Sep 2022, averaging 1.97% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.47 days on 31 May 2022. Full history: CAPRICOR THERAPEUTICS, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for CAPRICOR THERAPEUTICS, INC. in 2022

2022 in figures

Start of year
2.28% (14 Jan 2022)
End of year
1.35% (30 Dec 2022)
Change
-0.93 pp
High
3.87% (31 Jan 2022)
Low
0.88% (15 Sep 2022)
Average
1.97%
Highest days to cover
6.47 (31 May 2022)
SEC filings marked
8

Every report in 2022

CAPRICOR THERAPEUTICS, INC. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20222.28%4.13
31 Jan 20223.87%1.00
15 Feb 20223.60%2.64
28 Feb 20223.75%4.76
15 Mar 20222.96%3.84results (8-K), 10-K filed
31 Mar 20222.86%1.75
14 Apr 20222.66%3.75
29 Apr 20222.41%5.98
13 May 20222.31%5.49results (8-K), 10-Q filed
31 May 20222.11%6.47
15 Jun 20222.05%5.04
30 Jun 20221.80%2.51
15 Jul 20221.62%2.91
29 Jul 20221.48%3.74
15 Aug 20221.25%1.81results (8-K), 10-Q filed
31 Aug 20221.18%1.19
15 Sep 20220.88%1.13
30 Sep 20221.36%1.46
14 Oct 20221.22%1.16
31 Oct 20221.02%1.85
15 Nov 20221.03%1.5810-Q filed, results (8-K)
30 Nov 20220.94%1.80
15 Dec 20221.23%2.82
30 Dec 20221.35%3.45

See also: CAPRICOR THERAPEUTICS, INC.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.